Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine (Q83967473)
Jump to navigation
Jump to search
scientific article published on 26 April 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine |
scientific article published on 26 April 2011 |
Statements
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine (English)
Mizue Terai
David Berd
Inna Chervoneva
Kashyap Patel
Michael J Mastrangelo